Raymond Stevens, Ph.D.

Raymond Stevens, Ph.D.

Chief Executive Officer and DirectoratStructure Therapeutics· In proxies 2021–2025

Pay in FY2025+47% from the year before · Structure Therapeutics stock +156.5% the same year

Raymond Stevens, Ph.D. was paid $8.4M in FY2025 (Dec), up 47%. Structure Therapeutics stock rose 156.5% that year.

Pay$100 in the stock at the end of FY23 → $171
Pay is from the Summary Compensation Table of each Structure Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Structure TherapeuticsPublic company · 4 yr
    • Chief Executive Officer and Director2022 – Present · 4 yrStock in role -17%
  2. Danaher Corp /De/Public company · 5 yr
    • Director2021 – Present · 5 yrNo stock prices for these years
  3. Danaher CorporationPublic company
    • Director? – PresentNo stock prices for these years
  4. Structure TherapeuticsPublic company
    • Director? – PresentNo stock prices for these years
  5. Receptos Inc.Public company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Boards1

  • Danaher Corp /De/Director · 6 yr on the boardIndependentAudit, Science & Technology—Paid as an executive

Board seats come from each company's latest proxy statement.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?